BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37659203)

  • 21. USP14 as a novel prognostic marker promotes cisplatin resistance via Akt/ERK signaling pathways in gastric cancer.
    Fu Y; Ma G; Liu G; Li B; Li H; Hao X; Liu L
    Cancer Med; 2018 Nov; 7(11):5577-5588. PubMed ID: 30296012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of the Epithelial-Mesenchymal Transition (EMT) with Cisplatin Resistance.
    Ashrafizadeh M; Zarrabi A; Hushmandi K; Kalantari M; Mohammadinejad R; Javaheri T; Sethi G
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32503307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Annexin A1 induces oxaliplatin resistance of gastric cancer through autophagy by targeting PI3K/AKT/mTOR.
    Ren J; Hu Z; Niu G; Xia J; Wang X; Hong R; Gu J; Wang D; Ke C
    FASEB J; 2023 Mar; 37(3):e22790. PubMed ID: 36786694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of CD133 Overcomes Cisplatin Resistance Through Inhibiting PI3K/AKT/mTOR Signaling Pathway and Autophagy in CD133-Positive Gastric Cancer Cells.
    Lu R; Zhao G; Yang Y; Jiang Z; Cai J; Hu H
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819864311. PubMed ID: 31405336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrated epigenomics identifies BMP4 as a modulator of cisplatin sensitivity in gastric cancer.
    Ivanova T; Zouridis H; Wu Y; Cheng LL; Tan IB; Gopalakrishnan V; Ooi CH; Lee J; Qin L; Wu J; Lee M; Rha SY; Huang D; Liem N; Yeoh KG; Yong WP; Teh BT; Tan P
    Gut; 2013 Jan; 62(1):22-33. PubMed ID: 22535375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long Noncoding RNA Plasmacytoma Variant Translocation 1 Regulates Cisplatin Resistance via miR-3619-5p/TBL1XR1 Axis in Gastric Cancer.
    Wu C; Hu Y; Ning Y; Zhao A; Zhang G; Yan L
    Cancer Biother Radiopharm; 2020 Dec; 35(10):741-752. PubMed ID: 32407172
    [No Abstract]   [Full Text] [Related]  

  • 27. Inhibition of PDGFR by CP-673451 induces apoptosis and increases cisplatin cytotoxicity in NSCLC cells via inhibiting the Nrf2-mediated defense mechanism.
    Yang Y; Deng Y; Chen X; Zhang J; Chen Y; Li H; Wu Q; Yang Z; Zhang L; Liu B
    Toxicol Lett; 2018 Oct; 295():88-98. PubMed ID: 29857117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-492 promotes chemoresistance to CDDP and metastasis by targeting inhibiting DNMT3B and induces stemness in gastric cancer.
    Wu S; Xie J; Shi H; Wang ZW
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32065219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression.
    Huang X; Li Z; Zhang Q; Wang W; Li B; Wang L; Xu Z; Zeng A; Zhang X; Zhang X; He Z; Li Q; Sun G; Wang S; Li Q; Wang L; Zhang L; Xu H; Xu Z
    Mol Cancer; 2019 Mar; 18(1):71. PubMed ID: 30927924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracellular MUC20 variant 2 maintains mitochondrial calcium homeostasis and enhances drug resistance in gastric cancer.
    Fu L; Yonemura A; Yasuda-Yoshihara N; Umemoto T; Zhang J; Yasuda T; Uchihara T; Akiyama T; Kitamura F; Yamashita K; Okamoto Y; Bu L; Wei F; Hu X; Liu Y; Ajani JA; Tan P; Baba H; Ishimoto T
    Gastric Cancer; 2022 May; 25(3):542-557. PubMed ID: 35166958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Propofol facilitates cisplatin sensitivity via lncRNA MALAT1/miR-30e/ATG5 axis through suppressing autophagy in gastric cancer.
    Zhang YF; Li CS; Zhou Y; Lu XH
    Life Sci; 2020 Mar; 244():117280. PubMed ID: 31926239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of MGMT-mediated autophagy suppression decreases cisplatin chemosensitivity in gastric cancer.
    Lei Y; Tang L; Hu J; Wang S; Liu Y; Yang M; Zhang J; Tang B
    Biomed Pharmacother; 2020 May; 125():109896. PubMed ID: 32007918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-101 alleviates chemoresistance of gastric cancer cells by targeting ANXA2.
    Bao J; Xu Y; Wang Q; Zhang J; Li Z; Li D; Li J
    Biomed Pharmacother; 2017 Aug; 92():1030-1037. PubMed ID: 28609840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Linc00852 from cisplatin-resistant gastric cancer cell-derived exosomes regulates COMMD7 to promote cisplatin resistance of recipient cells through microRNA-514a-5p.
    Cao S; Fu B; Cai J; Zhang D; Wang C; Wu H
    Cell Biol Toxicol; 2023 Apr; 39(2):483-496. PubMed ID: 35088190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exosomes Serve as Nanoparticles to Deliver Anti-miR-214 to Reverse Chemoresistance to Cisplatin in Gastric Cancer.
    Wang X; Zhang H; Bai M; Ning T; Ge S; Deng T; Liu R; Zhang L; Ying G; Ba Y
    Mol Ther; 2018 Mar; 26(3):774-783. PubMed ID: 29456019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exosome-Derived Circ-PVT1 Contributes to Cisplatin Resistance by Regulating Autophagy, Invasion, and Apoptosis Via miR-30a-5p/YAP1 Axis in Gastric Cancer Cells.
    Yao W; Guo P; Mu Q; Wang Y
    Cancer Biother Radiopharm; 2021 May; 36(4):347-359. PubMed ID: 32799541
    [No Abstract]   [Full Text] [Related]  

  • 37. Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects.
    Abadi AJ; Mirzaei S; Mahabady MK; Hashemi F; Zabolian A; Hashemi F; Raee P; Aghamiri S; Ashrafizadeh M; Aref AR; Hamblin MR; Hushmandi K; Zarrabi A; Sethi G
    Phytother Res; 2022 Jan; 36(1):189-213. PubMed ID: 34697839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Zuo Jin Wan Formula increases chemosensitivity of human primary gastric cancer cells by AKT mediated mitochondrial translocation of cofilin-1.
    Sun MY; Wang DD; Sun J; Zhao XH; Cai S; Wu QX; Jie T; Ni ZH; Sun JY; Tang QF
    Chin J Nat Med; 2019 Mar; 17(3):198-208. PubMed ID: 30910056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. circ-LDLRAD3 Knockdown Reduces Cisplatin Chemoresistance and Inhibits the Development of Gastric Cancer with Cisplatin Resistance through miR-588 Enrichment-Mediated SOX5 Inhibition.
    Liang Q; Chu F; Zhang L; Jiang Y; Li L; Wu H
    Gut Liver; 2023 May; 17(3):389-403. PubMed ID: 35975639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lung cancer cells and their sensitivity/resistance to cisplatin chemotherapy: Role of microRNAs and upstream mediators.
    Ashrafizadeh M; Zarrabi A; Hushmandi K; Hashemi F; Moghadam ER; Owrang M; Hashemi F; Makvandi P; Goharrizi MASB; Najafi M; Khan H
    Cell Signal; 2021 Feb; 78():109871. PubMed ID: 33279671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.